Integrative Medicine Case Reports

Register      Login

VOLUME 5 , ISSUE 1 ( January, 2024 ) > List of Articles


Plausible role of homoeopathic intervention in the management of Tinea Faciei; A case series

SK. Samim Parvez, Sourita Das, Shuvasree Bhattacharya, Pratima Pramanik, Avirup Basu, SK Swaif Ali, Debojyoti Singha, Saptarshi Choudhury, Pritam Goswami

Keywords : Dermatophytosis, Individualized Homeopathy, Tinea faciei, Natrum muriaticum, Nux vomica

Citation Information : Samim Parvez S, Das S, Bhattacharya S, Pramanik P, Basu A, Swaif Ali S, Singha D, Choudhury S, Goswami P. Plausible role of homoeopathic intervention in the management of Tinea Faciei; A case series. Integr Med Case Rep 2024; 5 (1):18-30.

DOI: 10.38205/imcr.050118

License: CC BY-NC 4.0

Published Online: 15-06-2024

Copyright Statement:  Copyright © 2024; Swami Paramhansa Swastha Siksha Evam Paryavaran Sanrakshan Samiti


Around the globe, dermatophyte infections are an increasingly prevalent type of superficial fungal infection. Several dermatophytes have a varying global distribution, where few are confined themselves to a region in particular. The nosological name of superficial dermatophyte infection varies according the location of the body, but in particular the variant that affects skin of the face is known as tinea faciei. It is frequently clinically misdiagnosed due to its variable appearance. The lancet reported it as an epidemic of fungal infection and nowadays occurrence has been fairly common OPDs and in clinical practice. Despite of being common in occurrence dermatophytosis is still a neglected topic in medical research. Different level of evidences like caser-report, case-series and RCT has been published on dermatophytosis but till date no evidence has been reported on tinea faciei only. Apart from quality of life tinea faciei has a significant impact as it can cause cosmetic disfigurement due to it's site. Here we are reporting about five cases of tinea faciei which has been managed efficiently with the help of individualized homeopathic medicine. Natrum muriaticum and Nux vomica was commonly indicated in the cases what we have treated. In all the cases significant improvement was seen without any further complications. In three out of five cases the patient was previously treated with anti-fungal combinations without much benefit, which depicts why homeopathy should be considered in the possible integration in the treatment of such fungal diseases. Though we couldn't specify the strains because of not having proper infrastructure but that is not essential for the successful homeopathic prescription. In future more structure and well designed clinical trial is desired to understand the scope and limitations for better clinical application.

PDF Share
  1. Lee HJ, Jeong SE, Lee S, Kim S, Han H, Jeon CO. Effects of cosmetics on the skin microbiome of facial cheeks with different hydration levels. Microbiologyopen. 2018 Apr;7(2):e00557.
  2. Gupta CM, Tripathi K, Tiwari S, Rathore Y, Nema S, Dhanvijay AG. Current trends of clinicomycological profile of dermatophytosis in Central India. IOSR-JDMS. 2014;13(10):23–6.
  3. Emmons, C.W. Dermatophytes: Natural grouping based on the form of the spores and accessory organs. Arch. Derm. Syphilol. 1934, 30, 337–362.
  4. de Hoog, G.S.; Dukik, K.; Monod, M.; Packeu, A.; Stubbe, D.; Hendrickx, M.; Kupsch, C.; Stielow, J.B.; Freeke, J.; Göker, M.; et al. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia 2017, 182, 5–31.
  5. Philpot, C.M. Geographical distribution of the dermatophytes: A review. Epidemiol. Infect. 1978, 80, 301–313.
  6. Seebacher, C.; Bouchara, J.-P.; Mignon, B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008, 166, 335–352.
  7. Monod, M.; Jaccoud, S.; Zaugg, C.; Léchenne, B.; Baudraz, F.; Panizzon, R. Survey of dermatophyte infections in the Lausanne area Switzerland. Dermatology 2002, 205, 201–203.
  8. Verma, S.B.; Panda, S.; Nenoff, P.; Singal, A.; Rudramuruthy, S.M.; Uhrlass, S.; Das, S.; Bisherwal, K.; Shaw, D.; Vasani, R. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J. Dermatol. Venereol. Leprol. 2021, 87, 154–175.
  9. Ebert, A.; Monod, M.; Salamin, K.; Burmester, A.; Uhrlaß, S.; Wiegand, C.; Hipler, U.C.; Krüger, C.; Koch, D.; Wittig, F.; et al. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre study. Mycoses 2020, 63, 717–728.
  10. Kong, X.; Tang, C.; Singh, A.; Ahmed, S.A.; Al-Hatmi, A.M.S.; Chowdhary, A.; Nenoff, P.; Gräser, Y.; Hainsworth, S.; Zhan, P.; et al. Antifungal susceptibility and mutations in the squalene epoxidase gene in dermatophytes of the trichophyton mentagrophytes species complex. Antimicrob. Agents Chemother. 2021, 65, e0005621.
  11. Khurana, A.; Agarwal, A.; Agrawal, D.; Panesar, S.; Ghadlinge, M.; Sardana, K.; Sethia, K.; Malhotra, S.; Chauhan, A.; Mehta, N. Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris: A randomized clinical trial. JAMA. Dermatol. 2022, 158, 1269–1278.
  12. Ansar A, Farshchian M, Nazeri H, Ghiasian SA. Clinico-epidemiological and mycological aspects of tinea incognito in Iran: A 16-year study. Med Mycol J 2011;52(1):25–32.
  13. Nenoff P, Schetschorke C. Images in clinical medicine. Tinea faciei. N Engl J Med 2014;15;370(20):e31.
  14. Nenoff P, Verma SB, Vasani R, Burmester A, Hipler UC, Wittig F, et al. The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes: A molecular study. Mycoses. 2019;62:336–56.
  15. Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: An appraisal. Indian journal of dermatology. 2017 May;62(3):227.
  16. Rajagopalan, M., Inamadar, A., Mittal, A. et al. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India). BMC Dermatol 18, 6 (2018).
  17. Dogra S; Narang T. Emerging Atypical and Unusual Presentations of Dermatophytosis in India. Clinical Dermatology Review 1 (Suppl 1):p S12-S18, October 2017.
  18. Kushwaha Pragya, Thakur Rameshwari, Kumar Harish and Avneet Singh Kalsi. 2017. Clinical Manifestations and Diagnostic Challenges of Tinea faciei. Int. J. Curr. Microbiol. App. Sci. 6(12): 1286–1294.
  19. Das S; Bandyopadhyay S; Sawant S; Chaudhuri S. Dermatophytosis Research Group. The Epidemiological and Mycological Profile of Superficial Mycoses in India from 2015 to 2021: A Systematic Review. Indian Journal of Public Health 67(1):p 123–135, Jan–Mar 2023.
  20. Simonart T, Kabagabo C, De Maertelaer V. Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials. Br J Dermatol. 2011;165(4):897–905.
  21. Roy, P., Tabassum, S., Das, S., Fouzdar, V., Hazra, A., & Goswami, P. (2021, December 25). Efficacy of individualized homeopathic treatment in the management of Dermatophytosis- A Case Series. International Journal of AYUSH Case Reports, 5(4), 321–332.
  22. Verma SB. Complex Cost Issues in Treating Dermatophytoses in India-“It All Builds Up”. Indian Dermatol Online J. 2019;10(4):441–443.
  23. Sardana, K.; Gupta, A.; Mathachan, S.R. Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections. Indian Dermatol. Online J. 2021, 12, 389–399.
  24. Calderon, R.A. Immunoregulation in dermatophytosis. Crit. Rev. Microbiol. 1989, 16, 339–368.
  25. Jartarkar, S.R.; Patil, A.; Goldust, Y.; Cockerell, C.J.; Schwartz, R.A.; Grabbe, S.; Goldust, M. Pathogenesis, Immunology and Management of Dermatophytosis. J. Fungi 2022, 8, 39.
  26. Reis, A.P.C.; Correia, F.F.; Jesus, T.M.; Pagliari, C.; Sakai-Valente, N.Y.; Belda Júnior, W.; Criado, P.R.; Benard, G.; Sousa, M.G.T. In situ immune response in human dermatophytosis: Possible role of Langerhans cells (CD1a+) as a risk factor for dermatophytes infection. Rev. Inst. Med. Trop. Sao Paulo 2019, 61, e56.
  27. Tainwala, R.; Sharma, Y.K. Pathogenesis of dermatophytoses. Indian J. Dermatol. 2011, 56, 259–261.
  28. Dahl, M.V. Dermatophytosis and the immune response. J. Am. Acad. Dermatol. 1994, 3 Pt 2, S34–S41.
  29. Bressani, V.O.; Santi, T.N.; Domingues-Ferreira MAlmeida, A.; Duarte, A.J.; Moraes-Vasconcelos, D. Characterization of the cellular immunity in patients presenting extensive dermatophytoses due to Trichophyton rubrum. Mycoses 2013, 56, 281–288.
  30. Brasch, J. Current knowledge of host response in human tinea. Mycoses 2009, 52, 304–312.
  31. Waldman, A.; Segal, R.; Berdicevsky, I.; Gilhar, A. CD4+ and CD8+T cells mediated direct cytotoxic effect against Trichophyton rubrum and Trichophyton mentagrophytes. Int. J. Dermatol. 2010, 49, 149–157.
  32. Traynor, T.R.; Huffnagle, G.B. Role of chemokines in fungal infections. Med. Mycol. 2001, 39, 41–50.
  33. Al, H.M.; Fitzgerald, S.M.; Saoudian, M.; Krishnaswamy, G. Dermatology for the practicing allergist, Tinea pedis and its complications. Clin. Mol. Allergy 2004, 2, 5.
  34. Saraiva, M.; O'garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10, 170.
  35. Bellavite P, Conforti A, Pontarollo F, Ortolani R. Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med. 2006;3(1):13–24.
  36. Margarito RA et al. Natrum muriaticum modifies productive response variables in Salicornia bigelovii (Torr.). Rev. Mex. Science. Agríc [online]. 2022, vol.13, n.spe28, pp.161–172. Epub 13-Jan-2023. ISSN 2007–0934.
  37. Reis, A. C. B. dos, & Ottoni, J. R. (2021). Antifungal activity of homeopathic medicines against the white mold causing agent Sclerotinia sclerotiorum. Acta Scientiarum. Biological Sciences, 43(1), e56548.
  38. Mercado CX, Kluthe BG. Fungicidal effects of homoeopathic medicines versus allopathic ketoconazole in Candida albicans. Indian J Res Homoeopathy 2021;15(4):229–236.
  39. Chinche, Anuj & Kathade, Suyash & Anand, Pashmin & Jadhav, Arun & Kunchiraman, Bipinraj & Shinde, Chetan & Shinde, Hanamantrao. (2018). “In – vitro study for anti-fungal activity of Homoeopathic Medicinesagainst plant fungus Ashbya gossypii”. 5. 466–470.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.